A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results